Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the P/E ratio high or low?
The P/E ratio of 2.93 is 23% below its 4-year average of 3.78, near the low end of its 4-year range (2.01–8.73).
As of 2026-10-06T19:18:14.478Z. 31.35% below its 12-month average of 4.27.
Calculation as of: 2026-10-06T19:18:14.478Z.
Quote observation: 2026-10-06T19:15:26.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: e871ea8067f28394f736e732b3966b53b535a0e4ae5ed833c49956b30cd07697
PE Ratio (2.93) = Close Price ($8.18) / Diluted TTM EPS ($2.79)
PE RATIO
2.93
PE RATIO AVG TTM
4.27
PE RATIO AVG 3Y
4.27
PE RATIO AVG 5Y
N/A
PE RATIO AVG 10Y
N/A
PE RATIO AVG 15Y
N/A
PE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-31.35%
CURRENT VS 3Y AVG
-31.35%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
25.56
median of 187 covered companies
CURRENT VS SECTOR MEDIAN
-88.54%
vs the sector median at left
Market Cap
$241.12M
PE Ratio
N/A
TTM Avg
50.66
3Y Avg
50.25
5Y Avg
404.96
| NAME | MARKET CAP | PE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Q32 Bio Inc. (QTTB) | $243.47M | 2.93 | 4.27 | 4.27 | N/A |
| Quantum-Si incorporated (QSI)vs › | $243.32M | N/A | N/A | N/A | N/A |
| Galectin Therapeutics Inc. (GALT)vs › | $243.67M | N/A | 2.96 | 2.96 | 2.96 |
| Lifecore Biomedical, Inc. (LFCR)vs › | $241.94M | N/A | 80.39 | 80.39 | 80.39 |
| Century Therapeutics, Inc. (IPSC)vs › | $245.36M | N/A | N/A | N/A | N/A |
| Sol-Gel Technologies Ltd. (SLGL)vs › | $241.12M | N/A | 50.66 | 50.25 | 404.96 |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $240.61M | N/A | N/A | N/A | N/A |
| High Tide Inc. (HITI)vs › | $238.57M | N/A | N/A | N/A | N/A |
| Upstream Bio, Inc. (UPB)vs › | $248.70M | N/A | N/A | N/A | N/A |
| Invivyd, Inc. (IVVD)vs › | $237.13M | N/A | N/A | N/A | N/A |
At 2.9, P/E is near its 4-year median — higher than 42% of readings in its 4-year history.
4-year low
2.0
median
3.2
4-year high
8.7
Trailing P/E
2.9
Forward P/E
N/A
Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.
Calculation:
Current Price
$8.18
Forward EPS (Est.)
$-1.49
Forward P/E
N/A
Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PE RATIO |
|---|---|
| 2026-10-05 | 3.00 |
| 2026-10-02 | 2.95 |
| 2026-10-01 | 2.96 |
| 2026-09-30 | 2.96 |
| 2026-09-29 | 3.42 |
| 2026-09-28 | 3.31 |
| 2026-09-25 | 3.14 |
| 2026-09-24 | 3.30 |
| 2026-09-23 | 3.43 |
| 2026-09-22 | 3.79 |
| 2026-09-21 | 3.75 |
| 2026-09-18 | 3.78 |
| 2026-09-17 | 3.89 |
| 2026-09-16 | 3.94 |
| 2026-09-15 | 4.00 |
| 2026-09-14 | 3.91 |
| 2026-09-11 | 3.98 |
| 2026-09-10 | 3.84 |
| 2026-09-09 | 3.99 |
| 2026-09-08 | 4.19 |
| 2026-09-04 | 4.30 |
| 2026-09-03 | 4.59 |
| 2026-09-02 | 4.87 |
| 2026-09-01 | 5.15 |
| 2026-08-31 | 5.33 |
| 2026-08-28 | 5.39 |
| 2026-08-27 | 5.79 |
| 2026-08-26 | 5.80 |
| 2026-08-25 | 5.85 |
| 2026-08-24 | 5.86 |
| 2026-08-21 | 5.72 |
| 2026-08-20 | 5.68 |
| 2026-08-19 | 5.68 |
| 2026-08-18 | 5.48 |
| 2026-08-17 | 5.72 |
| 2026-08-14 | 5.43 |
| 2026-08-13 | 5.51 |
| 2026-08-12 | 5.51 |
| 2026-08-11 | 5.52 |
| 2026-08-10 | 5.62 |
| 2026-08-07 | 5.59 |
| 2026-08-06 | 5.81 |
| 2026-08-05 | 6.73 |
| 2026-08-04 | 6.60 |
| 2026-08-03 | 6.19 |
| 2026-07-31 | 6.40 |
| 2026-07-30 | 6.35 |
| 2026-07-29 | 5.98 |
| 2026-07-28 | 6.41 |
| 2026-07-27 | 6.21 |
| 2026-07-24 | 6.18 |
| 2026-07-23 | 6.28 |
| 2026-07-22 | 6.16 |
| 2026-07-21 | 6.29 |
| 2026-07-20 | 6.14 |
| 2026-07-17 | 6.14 |
| 2026-07-16 | 6.21 |
| 2026-07-15 | 6.41 |
| 2026-07-14 | 7.53 |
| 2026-07-13 | 8.73 |
| 2026-07-10 | 4.58 |
| 2026-07-09 | 5.14 |
| 2026-07-08 | 5.75 |
| 2026-07-07 | 5.56 |
| 2026-07-06 | 5.25 |
| 2026-07-02 | 5.34 |
| 2026-07-01 | 5.14 |
| 2026-06-30 | 5.20 |
| 2026-06-29 | 5.77 |
| 2026-06-26 | 5.38 |
| 2026-06-25 | 4.88 |
| 2026-06-24 | 4.56 |
| 2026-06-23 | 4.85 |
| 2026-06-22 | 5.16 |
| 2026-06-18 | 4.86 |
| 2026-06-17 | 5.27 |
| 2026-06-16 | 5.20 |
| 2026-06-15 | 5.25 |
| 2026-06-12 | 5.16 |
| 2026-06-11 | 5.18 |
| 2026-06-10 | 5.25 |
| 2026-06-09 | 4.85 |
| 2026-06-08 | 4.91 |
| 2026-06-05 | 5.35 |
| 2026-06-04 | 5.71 |
| 2026-06-03 | 4.98 |
| 2026-06-02 | 5.16 |
| 2026-06-01 | 4.76 |
| 2026-05-29 | 4.51 |
| 2026-05-28 | 4.21 |
| 2026-05-27 | 5.24 |
| 2026-05-26 | 2.89 |
| 2026-05-22 | 2.37 |
| 2026-05-21 | 2.24 |
| 2026-05-20 | 2.31 |
| 2026-05-19 | 2.48 |
| 2026-05-18 | 2.35 |
| 2026-05-15 | 2.57 |
| 2026-05-14 | 2.55 |
| 2026-05-13 | 2.42 |
| 2026-05-12 | 2.37 |
| 2026-05-11 | 2.11 |
| 2026-05-08 | 2.19 |
| 2026-05-07 | 2.22 |
| 2026-05-06 | 2.23 |
| 2026-05-05 | 2.46 |
| 2026-05-04 | 2.41 |
| 2026-05-01 | 2.41 |
| 2026-04-30 | 2.68 |
| 2026-04-29 | 2.63 |
| 2026-04-28 | 2.74 |
| 2026-04-27 | 2.62 |
| 2026-04-24 | 2.98 |
| 2026-04-23 | 3.10 |
| 2026-04-22 | 3.18 |
| 2026-04-21 | 3.07 |
| 2026-04-20 | 3.18 |
| 2026-04-17 | 2.80 |
| 2026-04-16 | 2.74 |
| 2026-04-15 | 2.91 |
| 2026-04-14 | 2.81 |
| 2026-04-13 | 2.59 |
| 2026-04-10 | 2.42 |
| 2026-04-09 | 2.35 |
| 2026-04-08 | 2.62 |
| 2026-04-07 | 2.82 |
| 2026-04-06 | 2.70 |
| 2026-04-02 | 3.05 |
| 2026-04-01 | 2.92 |
| 2026-03-31 | 3.07 |
| 2026-03-30 | 2.82 |
| 2026-03-27 | 3.47 |
| 2026-03-26 | 3.42 |
| 2026-03-25 | 3.47 |
| 2026-03-24 | 3.49 |
| 2026-03-23 | 3.23 |
| 2026-03-20 | 3.20 |
| 2026-03-19 | 3.19 |
| 2026-03-18 | 2.78 |
| 2026-03-17 | 2.93 |
| 2026-03-16 | 3.01 |
| 2026-03-13 | 3.26 |
| 2026-03-12 | 3.37 |
| 2026-03-11 | 3.31 |
| 2023-05-11 | 2.20 |
| 2023-05-10 | 2.16 |
| 2023-05-09 | 2.25 |
| 2023-05-08 | 2.23 |
| 2023-05-05 | 2.21 |
| 2023-05-04 | 2.17 |
| 2023-05-03 | 2.15 |
| 2023-05-02 | 2.03 |
| 2023-05-01 | 2.07 |
| 2023-04-28 | 2.10 |
| 2023-04-27 | 2.09 |
| 2023-04-26 | 2.11 |
| 2023-04-25 | 2.14 |
| 2023-04-24 | 2.19 |
| 2023-04-21 | 2.16 |
| 2023-04-20 | 2.20 |
| 2023-04-19 | 2.27 |
| 2023-04-18 | 2.25 |
| 2023-04-17 | 2.32 |
| 2023-04-14 | 2.27 |
| 2023-04-13 | 2.23 |
| 2023-04-12 | 2.19 |
| 2023-04-11 | 2.20 |
| 2023-04-10 | 2.19 |
| 2023-04-06 | 2.23 |
| 2023-04-05 | 2.21 |
| 2023-04-04 | 2.23 |
| 2023-04-03 | 2.21 |
| 2023-03-31 | 2.27 |
| 2023-03-30 | 2.09 |
| 2023-03-29 | 2.23 |
| 2023-03-28 | 2.21 |
| 2023-03-27 | 2.10 |
| 2023-03-24 | 2.01 |
| 2023-03-23 | 2.03 |
| 2023-03-22 | 2.12 |
| 2023-03-21 | 2.36 |
| 2023-03-20 | 2.01 |
| 2023-03-17 | 2.10 |
| 2023-03-16 | 2.16 |
| 2023-03-15 | 2.23 |
| 2023-03-14 | 2.36 |
| 2023-03-13 | 2.41 |
| 2023-03-10 | 2.72 |